A Tamil Nadu government report has detailed extensive violations at Sresan Pharmaceutical, manufacturer of the Coldrif cough syrup associated with the deaths of 14 children in Madhya Pradesh and two in Rajasthan. The 26-page report, accessed by India Today TV, was compiled following an inspection by the Tamil Nadu Drugs Control Department. Advertisement

Investigators found over 350 lapses, identifying both critical and major failings. Sresan Pharmaceutical lacked basic facilities, had no qualified personnel, and failed to implement procedures necessary for product safety. Several states have suspended sale and use of the syrup pending further analysis and legal action.

Inspectors observed that Coldrif syrup was produced in severely unhygienic conditions. The facility had no air handlin

See Full Page